Results 121 to 130 of about 113,357 (162)
Some of the next articles are maybe not open access.
Urology, 1999
To enhance the specificity of prostate cancer (PCa) detection and reduce unnecessary biopsies in men with prostate-specific antigen (PSA) levels of 2.5 to 4.0 ng/mL, we prospectively evaluated various PSA-based diagnostic parameters.This study included 273 consecutive men with serum PSA of 2.5 to 4.0 ng/mL referred for early PCa detection or lower ...
B, Djavan +6 more
openaire +2 more sources
To enhance the specificity of prostate cancer (PCa) detection and reduce unnecessary biopsies in men with prostate-specific antigen (PSA) levels of 2.5 to 4.0 ng/mL, we prospectively evaluated various PSA-based diagnostic parameters.This study included 273 consecutive men with serum PSA of 2.5 to 4.0 ng/mL referred for early PCa detection or lower ...
B, Djavan +6 more
openaire +2 more sources
American Journal of Clinical Oncology, 2015
The objective of the study was to investigate prostate-specific antigen (PSA) nadir (nPSA) and time to nPSA (TnPSA) as prognostic variables for outcomes after definitive high-dose (>75 Gy) external beam radiation therapy (RT) without androgen deprivation therapy while correcting for immortal-time bias.nPSA and TnPSA were available for 410 patients ...
Skyler B, Johnson +4 more
openaire +2 more sources
The objective of the study was to investigate prostate-specific antigen (PSA) nadir (nPSA) and time to nPSA (TnPSA) as prognostic variables for outcomes after definitive high-dose (>75 Gy) external beam radiation therapy (RT) without androgen deprivation therapy while correcting for immortal-time bias.nPSA and TnPSA were available for 410 patients ...
Skyler B, Johnson +4 more
openaire +2 more sources
Urology, 2000
To ascertain when the serum determination of the free prostate-specific antigen (PSA)/total PSA (fPSA/tPSA) ratio is clinically useful, and whether the identification of PSA or prostate-specific membrane antigen (PSM) mRNA in circulating cells has diagnostic advantages over the determination of their protein product.fPSA, tPSA, and the fPSA/tPSA ratio ...
BASSO, DANIELA +8 more
openaire +2 more sources
To ascertain when the serum determination of the free prostate-specific antigen (PSA)/total PSA (fPSA/tPSA) ratio is clinically useful, and whether the identification of PSA or prostate-specific membrane antigen (PSM) mRNA in circulating cells has diagnostic advantages over the determination of their protein product.fPSA, tPSA, and the fPSA/tPSA ratio ...
BASSO, DANIELA +8 more
openaire +2 more sources
The Journal of Immunology, 2007
Abstract The murine MAb-AR47.47 (IgG1κ) recognizes all circulating forms of PSA and targets the epitope EPEEFLT. In vitro studies showed that human and murine dendritic cells process PSA more efficiently in immune complexes (IC) with MAb-AR47.47.
Birgit Corinna Schultes +4 more
openaire +1 more source
Abstract The murine MAb-AR47.47 (IgG1κ) recognizes all circulating forms of PSA and targets the epitope EPEEFLT. In vitro studies showed that human and murine dendritic cells process PSA more efficiently in immune complexes (IC) with MAb-AR47.47.
Birgit Corinna Schultes +4 more
openaire +1 more source
Türk Üroloji Seminerleri/Turkish Urology Seminars, 2013
Omer Kutlu, Ismail Turker Koksal
openaire +1 more source
Omer Kutlu, Ismail Turker Koksal
openaire +1 more source
SERS-based biosensor for detection of f-PSA%: Implications for the diagnosis of prostate cancer
Talanta, 2023Yawen Liu, Hao Ma, Xiao Xia Han
exaly